| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.082 | 0.09 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |